Australia markets closed

NeuroBo Pharmaceuticals, Inc. (NRBO)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
3.1050+0.0450 (+1.47%)
As of 04:00PM EDT. Market open.
Show:
Income statement
Cash flow
Annual

Balance sheet

All numbers in thousands
Breakdown
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Assets
Current assets
Cash
Cash and cash equivalents
22,435
33,364
16,387
10,089
Total cash
22,435
33,364
16,387
10,089
Other current assets
64
168
-
48
Total current assets
22,512
33,532
16,584
10,683
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
282
30
326
348
Accumulated depreciation
-34
-28
-111
-63
Net property, plant and equipment
248
2
215
285
Other long-term assets
21
-
-
-
Total non-current assets
269
2
215
285
Total assets
22,781
33,534
16,799
10,968
Liabilities and stockholders' equity
Liabilities
Current liabilities
Accounts payable
821
708
830
2,575
Accrued liabilities
3,625
280
1,301
1,096
Other current liabilities
658
10,796
-
-
Total current liabilities
5,960
11,784
2,157
3,695
Non-current liabilities
Total non-current liabilities
136
0
45
70
Total liabilities
6,096
11,784
2,202
3,765
Stockholders' equity
Common stock
5
25
1
20
Retained earnings
-108,265
-95,795
-81,828
-66,544
Accumulated other comprehensive income
0
0
4
14
Total stockholders' equity
16,685
21,750
14,597
7,203
Total liabilities and stockholders' equity
22,781
33,534
16,799
10,968